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Fibromyalgia is a prevalent chronic pain syndrome that can
occur in women with widespread pain, fatigue, muscle stiffness,
depression, poor quality of life and anxiety. It might also be
associated with exacerbated psychological factors such as somati-
zation, helplessness and catastrophic thinking related to pain [1,2].
The accurate pathophysiology of this syndrome is not
completely known; however, some evidence shows that both
peripheral and central sensitization may affect the functioning of
descending inhibitory mechanisms and facilitatory pathways.
These impairments, in turn, can modify the pain perception and
sensory processing in the neurosystem and lead to emotional
behavior in a person experiencing pain [3]. We lack effective
approaches to the management of long-lasting pain symptoms,
and the pain experiences might affect sleep quality, physical
functioning and quality of life, which can maintain a continuous
cycle and sustain the experience of a chronic condition [4].
Brain neuromodulation therapies such as transcranial direct
current stimulation (tDCS) can decrease pain in ﬁbromyalgia. tDCS
might induce signiﬁcant analgesic effects when applied to the
primary motor cortex (M1) [5] and also a signiﬁcant antidepres-
sant effect when applied over the dorsolateral prefrontal cortex
(DLPFC) [6], but its beneﬁt for alleviating catastrophic thinking
related to pain in ﬁbromyalgia has never been investigated.
A decrease in pain might have a considerable impact on the
functional physical rehabilitation of patients with ﬁbromyalgia.
We describe our study in a female patient with ﬁbromyalgia for
21 years, diagnosed according to 1990 American College of
Rheumatology criteria, which was refractory to various therapeu-
tic interventions. Our application of active stimulation of the M1
and DLPFC was associated with a decrease in pain, anxiety and
level of catastrophic thinking related to pain.
Our 52-year-old patient had postpartum depression associated
with a severe and long-lasting cold after her ﬁrst child was born
22 years ago, 10 months after she was married. She experienced
multiple muscle spasms and felt intense and diffuse pain
progressing over time. She also reported that household tasks
(household chores plus care for her son and husband), associated
with professional commitments, became troublesome. She con-
sidered that these burdens resulted from her perfectionist
psychological proﬁle. The patient began to experience sleep
disorders, together with uncomfortable morning stiffness. She
consulted a rheumatologist and the clinical diagnosis was
ﬁbromyalgia.
At this time, she started using antidepressants and received
psychological therapy and rheumatology monitoring for a long
period. She experienced periods of decreased pain but periodically
began to feel widespread and intense pain symptoms, evenhttp://dx.doi.org/10.1016/j.rehab.2015.10.002
1877-0657/ 2015 Elsevier Masson SAS. All rights reserved.without plausible external triggers. She reported that when her
ﬁrst child was 2 years old, her mother died, and then her painful
condition worsened considerably. At that time, she was receiving
an anxiolytic associated with an antidepressant and started shiatsu
therapy associated with psychotherapy, together with rheumatol-
ogist monitoring. She conﬁrmed that the pain decreased after this
therapeutic approach, but in situations of emotional instability, the
pain symptoms returned and were intense. She replaced the
shiatsu therapy with global posture re-education, with good
results in controlling pain, but manifestations of painful crises
became a constant in her life.
Five years before the study, the patient began to feel an intense
pain in the right shoulder, cervical spine, right and left hips and
right knee, with multiple diagnoses after MRI and CT. Continuous
medication prescription was revised (i.e., the anxiolytic was
replaced by an anticonvulsant plus antidepressant); in addition,
she received an anti-inﬂammatory agent for 1 month. Symptoms
were relieved after this approach, but 1 year later, at menopause
onset, she had a very sharp worsening of pain, together with
emotional instability.
After signing informed consent, the patient was randomized to
receive 3 treatments (10 sessions of 20 min each for each
treatment, 30 sessions total, with an interval of 1 week between
treatment types: (1) active tDCS (2 mA) over M1, (2) sham tDCS
stimulation and (3) active tDCS (2 mA) over DLPFC. Adverse effects
were minor and not common (skin redness and tingling). With
DLPFC stimulation, pain score decreased 50%, trait-anxiety score
20% and ruminative catastrophism score related to pain 28.6%
(Table 1). With M1 stimulation, pain score decreased 46.7%, state-
anxiety score 33.3%, and depressive symptom score 11.8%. With
sham stimulation, pain score decreased 6.3% and state-anxiety
score 4% and ruminative catastrophism score increased 6.7%.
The relationship between pain and behavior is a consistent
aspect in the context of ﬁbromyalgia and other pain disorders. As
well, the intensity of the nociceptive-stimulus pain has been linked
to the activation of widespread central sensitization and psycho-
logical factors such as somatization, depression, helplessness,
anxiety and catastrophizing [2,3]. The central sensitization has
been described as combining an impaired descending inhibitory
mechanism and altered pain facilitatory pathways, whereas
catastrophizing is understood as a maintenance phenomenon of
the worst possible result of a situation, and the relationship
between the conditions equally worsens the results in future
situations [7]. Catastrophizing has been associated with impaired
neural pathways related to affective regulation and positively
linked to measures of physical disability in pain experiences [8]. In
this context, DLPFC is an important brain region for emotional
processing and is linked with downregulation of negative affective
conditions [5].
Our patient showed a considerable decrease in ruminative
catastrophism and in pain after stimulation of the DLPFC (Fig. 1),
Fig. 1. Pain scores on a visual analogue scale (VAS; 0–10) at baseline (day 1) and on days 2 to 10 before (pre) and after (post) each 10-session treatment.
Table 1
Scores for pain, disease, sleep and psychological scales before and after each transcranial direct current stimulation (tDCS) protocol.
Scales tDCS over M1 Sham tDCS tDCS over DLPFC
Before After Before After Before After
Pain, visual analogue scale (0–10) 7.5 4 (46.7%) 8 7.5 (6.3%) 7 3.5 (50%)
Fibromyalgia impact questionnaire (0–80) 69 65 (5.8%) 68 67 (1.5%) 66 61 (7.6%)
Brazilian state-trait anxiety inventory (0–100)
State-anxiety (0–52) 30 20 (33.3%) 25 24 (4%) 21 22 (4.8%)
Trait-anxiety (0–48) 31 32 (3.2%) 30 30 (0%) 30 24 (20%)
Beck depression inventory (0–63) 17 15 (11.8%) 19 19 (0%) 11 11 (0%)
Pain catastrophizing scale for the Brazilian population (0–52)
Rumination (0–16) 14 15 (7.4%) 15 16 (6.7%) 14 10 (28.6%)
Magniﬁcation (0–12) 9 9 (0%) 11 11 (0%) 10 9 (0%)
Helplessness (0–24) 18 19 (5.6%) 19 19 (0%) 17 17 (0%)
The values in parentheses express the percentage improvement compared with pre-intervention. MI: motor cortex; DLPFC: dorsolateral prefrontal cortex.
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networks involved in the emotional processing of pain perception.
These ﬁndings agree with studies of patients with chronic
neuropathic pain [8], which suggests that catastrophizing is
positively related to affective aspects of pain perception.
In the same context, anxiety is known to involve both
physiological and psychological aspects that affect sensorial
interpretation and associated with altered brain excitability
[9]. We found considerably decreased state-anxiety (i.e., with
references to an acute situation that changes over time) and trait-
anxiety (i.e., with references to personality pattern) after M1 and
DLPFC stimulation, respectively, in our patient. After stimulation,
the patient reported decreased pain perception, which agreed with
previous reports suggesting that anxiety levels are directly
proportional to a predisposition to the development of musculo-
skeletal pain [9]. Although the underlying mechanism between
pain and anxiety is not clear, our ﬁndings suggest that the
dysfunctional cortical processing in our patient could be modulat-
ed at least in part after M1 and DLPFC stimulation, thereby
contributing to decreased anxiety.
Our patient showed considerably decreased pain levels after M1
and DLPFC stimulation (Fig. 1). Nevertheless, we found few
antidepressant effects with tDCS with both stimulation types. This
ﬁnding disagrees with previous results, showing tDCS to the DLPFC
associated with ameliorated depressive symptoms in patients with
major depression [5]. However, our ﬁndings agree with those of
Fregni et al. [10], who showed lack of antidepressant effects
associated with tDCS as compared with sham stimulation inpatients with ﬁbromyalgia. In this context, the pathophysiologic
mechanisms of depression in ﬁbromyalgia differ from those of
major depression [2,5,10]. Furthermore, we observed the effects of
tDCS in only one patient presenting mildly severe depressive
symptoms, which might explain the results.
In our patient, sham tDCS stimulation had little effect on most
of the variables studied and increased the helplessness catastro-
phism. The lack of signiﬁcant reduction in anxiety level after sham
stimulation may indicate that the sham intervention did not affect
the psychological aspects involving the therapeutic effects.
Our results suggest that active stimulation of the M1 and the
DLPFC might decrease pain perception and anxiety levels. Besides
affecting pain level, the DLPFC stimulation seemed to have effects
on ruminative catastrophism.
One limitation to our study was that although we applied a
regimen of 10 daily tDCS sessions for each protocol, we did not
investigate the long-lasting effects of the therapy. However, this is
the ﬁrst assessment of the relationship between catastrophism and
ﬁbromyalgia. Future research investigating cortical excitability,
catastrophism and ﬁbromyalgia might provide more explanations
for our ﬁndings. Finally, this study was a case study that involved
only one patient, and studies with larger sample sizes might better
explore the present study results.
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